ClinicalTrials.gov record
Completed Not applicable Interventional

Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

ClinicalTrials.gov ID: NCT04770337

Public ClinicalTrials.gov record NCT04770337. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

STARSTIM: SAFETY AND THERAPEUTIC MEASURES OF TRANSCRANIAL CATHODAL DIRECT CURRENT STIMULATION (TDCS) IN PATIENTS WITH REFRACTORY FOCAL EPILEPSY

Study identification

NCT ID
NCT04770337
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Neuroelectrics Corporation
Industry
Enrollment
127 participants

Conditions and interventions

Eligibility (public fields only)

Age range
9 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 24, 2021
Primary completion
Jan 11, 2026
Completion
Jan 11, 2026
Last update posted
Apr 7, 2026

2021 – 2026

United States locations

U.S. sites
18
U.S. states
14
U.S. cities
16
Facility City State ZIP Site status
Barrow Neurological Institute, St. Joseph's Hospital & Medical Center Phoenix Arizona 85013
Loma Linda University Health Loma Linda California 92354
Keck Medicine of USC Los Angeles California 90033
Children's Hospital of Orange County Orange California 92868
University of Florida Jacksonville Jacksonville Florida 32209
Southern Illinois University School of Medicine Springfield Illinois 62702
Sinai Hospital Baltimore Maryland 21215
Johns Hopkins University Baltimore Maryland 21287
Boston Children's Hospital Comprehensive Epilepsy Center Boston Massachusetts 02115
Beth Israel Deconess Medical Center Boston Massachusetts 02215
Mayo Clinic Rochester Minnesota 55905
Washington University Medical Center St Louis Missouri 63110
Robert Wood Johnson Medical School (Rutgers) New Brunswick New Jersey 08901
University of Rochester Rochester New York 14642
University of Pennsylvania (Penn Epilepsy) Philadelphia Pennsylvania 19104
Vanderbilt University Medical Center Nashville Tennessee 37212
University Of Utah Salt Lake City Utah 84132
Seattle Children's Hospital, University of Washington Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04770337, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 7, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04770337 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →